SCHEMBL29611532

SCHEMBL29611532

O=C1CCC(N2C(=O)c3ccc(C4CCN(Cc5cc6ccccc6[nH]5)CC4)c4cccc2c34)C(=O)N1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKZF2 Q9UKS7 5/20 0.45
BCL2L11 O43521 1/20 0.41
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
CRBN Q96SW2 7/20 0.41
DDB1 Q16531 5/20 0.41
IKZF3 Q9UKT9 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CHRM2 P08172 1/20 0.41
OPRM1 P35372 1/20 0.41
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CCR8 P51685 1/20 0.40
IKZF1 Q13422 6/20 0.39
HRH4 Q9H3N8 1/20 0.39
TNF P01375 1/20 0.38
IL1B P01584 1/20 0.38
TBXA2R P21731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316326 1.00 IKZF2 (0.45) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL24315904 0.85 IKZF2 (0.60) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL29610888 0.85 IKZF2 (0.60) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL24329414 0.82 CRBN (0.48) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL24315764 0.82 IKZF2 (0.43) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL29611189 0.82 IKZF2 (0.43) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL24316227 0.81 IKZF2 (0.46) IKZF2CRBNDDB1IKZF3IKZF1
SCHEMBL29610533 0.81 IKZF2 (0.46) IKZF2CRBNDDB1IKZF3IKZF1
SCHEMBL31323484 0.81 CRBN (0.45) IKZF2BCL2L11BCL2MCL1CRBN
SCHEMBL24315890 0.81 IKZF2 (0.55) IKZF2BCL2L11BCL2MCL1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228639-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed